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INTRODUCTION: Therapeutic plasma exchange (TPE) can be proposed in the
treatment of chronic dysimmune peripheral neuropathies (CDPN). Actual
guidelines are however based on few studies, and indications and protocols still
remain to be clarified. We conducted a 10-year retrospective study in order to
assess the effectiveness and tolerance of TPE in CDPN.
METHODS: All patients treated for CDPN with TPE from October 2006 to March
2016 in the university hospital of Angers were included. Patients were considered
responders when they presented a clinical improvement substantial enough to
continue the treatment. The Hughes functional grading score was also determined
for each patient before and after TPE initiation.
RESULTS: Among the 206 patients who received TPE during the study period, 30
(14.6%) met the diagnostic criteria of CDPN. Four of the five paraprotein
neuropathies (PPN) patients (80%) and 8 of the 11 chronic inflammatory
demyelinating polyneuropathies (CIDP) patients (72.7%) were responders, with a
significant improvement of the Hughes score for the latter (P = 0.013). None of the
three Lewis-Sumner and the two POEMS patients showed substantial
improvement. Six of the nine anti-MAG neuropathy patients (66.7%) responded to
treatment, with a trend towards improvement of the Hughes score (P = 0.072).
CONCLUSION: TPE appears to be effective in CIDP and PPN, and ineffective in
Lewis-Sumner and POEMS syndromes. Interestingly, anti-MAG neuropathy
patients showed a good rate of response to TPE. Regarding these preliminary
results, a randomized trial would be very worthwhile in this disease for which
there is no evidence based treatment to date.
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